ABSTRACT
INTRODUCTION
Congenital heart disease (CHD), a major cause of infant mortality and morbidity, occurs in approximately 6-12 per 1000 live births 1 . From an obstetric viewpoint, it constitutes one of the most common congenital anomalies and accounts for approximately 8% of stillborn infants without chromosomal abnormalities 2 . While advances in early diagnosis and postnatal management have increased survival in children with CHD 3 , worrying long-term outcomes, particularly neurodevelopmental disability, have emerged as a key prognostic factor in the counseling of these pregnancies 4, 5 .
A recent study showed that a high proportion of fetuses with CHD have a smaller head and increased brain perfusion by the second trimester of pregnancy 6 . Additionally, a substantial percentage of newborns with CHD have signs of brain injury on magnetic resonance imaging (MRI) 5, 7, 8 and reduced cranial size 9, 10 , suggesting early onset of the mechanisms leading to poorer neurodevelopment later in life.
It has been hypothesized that altered cerebral perfusion is one of the main contributors to abnormal neurodevelopment in fetuses with CHD. However, although abnormal head size was more pronounced in fetuses with compromised blood delivery to the brain, it was also present in milder forms of CHD, suggesting that there could be additional mechanisms that contribute to abnormal neurodevelopment in CHD cases 6, 11 . We have reported that maternal serum placental growth factor (PlGF) is decreased at 11-13 weeks of gestation in cases of isolated major fetal heart defects, which indicates impaired placental angiogenesis 12 . Furthermore, higher antiangiogenic expression, characterized by soluble fms-like tyrosine kinase-1 (sFlt-1), vascular endothelial growth factor A and soluble endoglin, was observed in heart tissue and cord blood of fetuses with CHD compared to controls, and lower PlGF and higher sFlt-1 levels were found in maternal serum at 18-37 weeks of gestation, thereby indicating that these cases may have altered placental angiogenesis 13 . We sought to ascertain whether an impairment in fetal head and body growth develops throughout gestation and whether these changes are related to the expected type of oxygen brain supply in CHD cases. Moreover, we hypothesized that placental perfusion could be related to changes in fetal head and body size in cases of CHD.
SUBJECTS AND METHODS

Study population
This was a retrospective study of cases with CHD identified prenatally at one of two tertiary centers: BCNatal and Hospital Universitari Vall d'Hebrón, Barcelona, Spain. The study population consisted of pregnant women referred to the fetal cardiology units for fetal echocardiography from June 2010 to December 2014. Diagnosis of major CHD was the inclusion criterion. We considered as exclusion criteria gestational age < 20 weeks or > 25 weeks at referral, associated extracardiac malformation, chromosomal abnormality, associated fetal arrhythmia, maternal condition that might affect fetal hemodynamics, such as diabetes, thyroid disease or pre-eclampsia, multiple pregnancy and fetal anemia. The study protocol was approved by both hospitals' ethics committees.
Maternal age, gestational age at delivery, mode of delivery, presence of pre-eclampsia, sex, birth weight, birth-weight centile, birth length, head circumference (HC) at birth, Apgar scores and umbilical artery (UA) pH were recorded. Birth length and HC were converted into Z-scores using published normative data 14 . In order to analyze the effect of cerebral hemodynamics according to the expected main pattern of blood supply to the brain (placental (oxygenated, nutrient-rich) vs systemic (deoxygenated, nutrient-poor)) in different types of CHD, we stratified the study population, using a previously published classification 6, 11 as follows:
• Group 1: expected low placental blood content, including severe left outflow tract obstruction with reversed flow in the aortic isthmus (and thus retrograde cerebral blood perfusion from the ductus arteriosus), and transposition of the great arteries (TGA) with the aortic blood flow originating from the right ventricle.
• Group 2: expected intermediate placental and systemic blood content owing to intracardiac shunt (septal defects, conotruncal defects other than TGA and complex CHD).
• Group 3: expected high placental blood content, in which brain perfusion originated from the left ventricle via a correctly formed aorta (right CHD), including pulmonary stenosis, tricuspid atresia, Ebstein's anomaly and pulmonary atresia.
Ultrasound evaluation
Gestational age at ultrasound examination was calculated from the crown-rump length at first-trimester screening 15 . A complete ultrasound examination was performed in each fetus using a Voluson E8 (GE Healthcare Ultrasound, Milwaukee, WI, USA) or Siemens Sonoline Antares (Siemens Medical Systems, Malvern, PA, USA) ultrasound machine equipped with a 9-2-MHz convex curved transducer. Fetal echocardiographic examination was performed according to the International Society of Ultrasound in Obstetrics and Gynecology guidelines 16 . Briefly, cardiac axis and situs, pericardial effusions, ventricular morphology, venoatrial, atrioventricular and ventriculoarterial connections, size and relationships of left and right ventricular outflow tracts, ductal and aortic arches, atrial and interventricular septum and flow through atrioventricular and semilunar valves were evaluated using two-dimensional, color and pulsed Doppler ultrasound. Prenatal diagnosis of CHD was confirmed on postnatal echocardiography or at autopsy in cases of neonatal death.
Fetal biometric parameters biparietal diameter (BPD), HC, abdominal circumference (AC) and femur length (FL) were assessed and transformed into centiles for gestational age 17, 18 . Estimated fetal weight was calculated according to the method of Hadlock et al. 19 ; both estimated fetal weight and birth-weight centile were calculated using local reference curves 20 . Doppler recordings were made in the absence of fetal movements with voluntarily suspended maternal breathing. Measurements of pulsed Doppler parameters were taken automatically from three or more consecutive waveforms, with an angle of insonation as close as possible to 0
• . The UA was evaluated in a free loop of the umbilical cord 21 . The fetal middle cerebral artery (MCA) was measured in a transverse view of the skull at the level of its origin from the circle of Willis 21 . Cerebroplacental ratio (CPR) was calculated by dividing MCA by UA pulsatility index (PI) 22 . Uterine artery (UtA) was evaluated with the probe placed on the lower quadrant of the abdomen, angled medially, with identification by color Doppler imaging of the apparent crossover with the external iliac artery. Mean UtA-PI was calculated as the average PI of right and left arteries 23 . Doppler parameters were transformed into Z-scores and centiles according to their normal ranges [21] [22] [23] . MCA-PI and/or CPR < 5 th centile was interpreted as a sign of brain vasodilation/redistribution 22 . Mean UtA-PI > 95 th centile 23 and UA-PI > 95 th centile 21 were considered to be abnormal.
Statistical analysis
Data were analyzed using the IBM SPSS Statistics 21 (IBM Corp., Armonk, NY, USA) and Stata 13.1 (StataCorp, College Station, TX, USA) statistical packages. All parameters were converted into Z-scores using published normative data from a large population of healthy fetuses 17, 18, [21] [22] [23] . A Z-score of 0 was at the mean of the normal data and Z-scores of ±1 and ±2 were at 1 and 2 SD from the mean, respectively. Variables were expressed as mean ± SD or percentage. Doppler indices and biometric parameters were compared among groups using one-way analysis of variance (ANOVA). To control for Type-1 error inflation, post-hoc pairwise comparisons among diagnostic groups were carried out, by applying a Bonferroni correction to the P-value of each test. Dichotomous variables were analyzed using the χ 2 -test and Fisher's exact test, with P < 0.05 considered statistically significant. A linear mixed model was performed to analyze repeated measurements, with a quadratic trend component for gestational age included in the fixed effect. A random intercept and slope were included in the random-effect component. CHD grouping variables were included in the model and tested for interaction. Fixed-effect predictions were plotted against gestational weeks for better readability.
RESULTS
Four hundred and forty-four observations were recorded for 119 fetuses with CHD, with a median of two (range, Table 1 Characteristics of study group of 119 fetuses with congenital heart disease, classified according to expected pattern of blood supply to the brain 2-9) measurements for each. Delivery data for the study group are summarized in Table 1 . Distribution of CHD types according to expected pattern of blood supply to the brain is shown in Table 2 . There were 64 (53.8%) fetuses with an expected low placental blood content (Group 1), 35 (29.4%) with an expected intermediate placental and systemic blood content (Group 2) and 20 (16.8%) with expected high placental blood content (Group 3).
Comparison of biometric and Doppler parameters at the first examination in all 119 cases of CHD, classified into groups according to the expected pattern of brain blood supply, is shown in Table 3 . No significant differences were observed among groups with respect to gestational age at first ultrasound, estimated fetal weight and weight centile. CHD fetuses presented a small head (BPD Z-score, −1.32 ± 0.99, 9 th centile; HC Z-score, −0.79 ± 1.02, 21 st centile) but normal AC (Z-score, 0.49 ± 0.88, 69 th centile) and FL (Z-score, −0.04 ± 0.49, 48 th centile) at diagnosis. In 38% and in 25% of cases, respectively, BPD and HC were below the 5 th centile. Biometric variables at inclusion showed no significant differences among groups, with the exception of AC Z-score, which was higher in 
5 th centile at the first examination. When these parameters were analyzed according to the type of brain blood supply, UtA-PI and UA-PI showed no differences among groups; however, MCA-PI Z-score and CPR Z-score were significantly lower in the impaired brain blood supply groups (Groups 1 and 2) (P < 0.001 and P = 0.007, respectively).
Results of the linear mixed models for repeated measurements of biometric and Doppler parameters in CHD fetuses are shown in Table 4 . No differences among study groups were observed in the longitudinal analysis of head or body biometrics throughout gestation. Figure 1 shows the longitudinal behavior of biometric parameters in fetuses with CHD; 444 observations were recorded in 119 fetuses. The small head at diagnosis in CHD fetuses remained small throughout gestation ( Figure 1 ) and was confirmed at birth (HC Z-score, −0.56 ± 1.21, 31 st centile). Figure 2 shows the longitudinal behavior of Doppler variables; 391 observations were recorded in 119 fetuses. Both UA-PI and UtA-PI Z-scores showed quadratic increases with gestational age, which were more pronounced in the UtA Doppler. At the end of pregnancy, 61% of these women showed a mean UtA-PI above the 95 th centile. In contrast, MCA-PI and CPR Z-scores showed a non-significant trend towards increasing with gestation.
Comparison of MCA-PI Z-scores in the three CHD groups throughout gestation is shown in Figure 3 . MCA-PI Z-scores were lower in the group with an expected severe impairment of blood supply to the brain (Group 1) (P = 0.02). No differences were observed when analyzing behavior of this parameter with gestational age among the three CHD groups. Comparison of UtA-PI Z-scores in the three CHD groups throughout gestation is shown in Figure 4 . UtA-PI Z-scores were higher in the group with the expected best blood supply to the brain (Group 3), with all groups showing a significant quadratic increase with gestational age (P = 0.005).
DISCUSSION
Our data confirm that CHD fetuses have relatively small head biometry in the second trimester of pregnancy, reflected by low BPD and HC Z-scores. The main observations of this study were that head biometry remained smaller than normal throughout gestation and that placental hemodynamics showed impairment towards the end of pregnancy, regardless of the type of CHD anomaly.
CHD is associated with a relatively high prevalence of brain lesions on neuroimaging and a significant risk of neurodevelopmental delay. Although the association of complex CHD and abnormal neurodevelopment is well established 5 , the causes remain unclear. Disease-specific biometry is thought to be a consequence of diminished oxygen distribution and blood flow to the brain caused by abnormal heart morphology in fetuses with heart defects. A direct link between reduced cerebral oxygenation and impaired brain growth in fetuses with CHD was established recently using phase-contrast cardiac magnetic resonance 24 . We have reported that, in the third trimester of pregnancy, CHD fetuses presented significant changes in head biometry, brain perfusion, cortical development and brain metabolism, with signs of more severe alterations in cases with an expected severe reduction in brain oxygenated blood supply 11 . Although an association between decreasing MCA-PI and CPR values with the type of CHD based on the expected degree of oxygenation was observed, all CHD groups had smaller head biometry compared with published normal data 14 , confirming data from previous studies 6, 25 . Interestingly, our study demonstrated that these changes persisted towards the end of pregnancy and did not worsen with advancing gestational age, thereby suggesting that the cause of abnormal brain development could already be present from the beginning of pregnancy.
One interesting finding of our present study was that UA-PI and UtA-PI worsened towards the end of pregnancy, with 61% of cases showing a mean UtA-PI above the 95 th centile, indicating increased resistance in UtA vessels, suggesting a certain degree of placental impairment. Abnormal placentation was recently found to be related to CHD 12, 13 . Pregnant women with CHD have significantly more obstetric and offspring complications than do healthy women. Moreover, significantly higher incidences of pre-eclampsia, intrauterine growth restriction and stillbirth in mothers carrying a fetus with CHD were reported compared with the normal population 26 . In our present study, 5% of women developed pre-eclampsia and approximately 50% of newborns with CHD had a birth weight below the 5 th centile. Changes in plasma concentrations of angiogenic and antiangiogenic factors or their ratios in the mother imply a higher risk of her delivering a small-for-gestational-age neonate and/or developing pre-eclampsia [27] [28] [29] . Reduced maternal serum PlGF and increased sFlt-1 have been reported in patients with fetuses with valve and conotruncal heart defects 12, 13 . Furthermore, a correlation between lower maternal PlGF levels and birth-weight percentile in CHD infants has been reported 13 , suggesting that placental impairment contributes to diminished growth potential in fetuses with CHD. Using phase-contrast cardiac magnetic resonance, lower oxygen saturation in the umbilical vein of fetuses with CHD, which may reflect abnormal placental function, was reported recently 24, 30 . High incidences of placental abnormalities have been observed on pathology and histopathology 31 . Overall, these studies suggest that CHD may be associated with intrinsically altered placentation that is more pronounced at the end of pregnancy, with ensuing placental hypoxia. Currently, it is not routine to screen for pre-eclampsia or placental impairment in women with a CHD fetus. Based on the results of this study, we would recommend periodic ultrasound examination for fetal growth and Doppler evaluation, as well as screening for maternal pre-eclampsia, as part of the prenatal follow-up.
Different pathogenic pathways leading to prenatal abnormal brain development in CHD, other than abnormal heart anatomy, may also exist. Alternatively, there might be an intrinsically abnormal vessel formation. Donofrio and Massaro 4 stated that the difference between brain lesions in neonates with CHD and in those who sustained hypoxic ischemic injury suggested that acquired brain injury in CHD may be related to an abnormality in brain development. Licht et al. 32 , using a maturation score based on four parameters, including myelination, cortical infolding, involution of glial cell migration bands and the presence of germinal matrix tissues, found a delay in brain development in utero of approximately 1 month. Beca et al. 33 reported recently that severity of brain immaturity at birth predicts the level of neurodevelopmental impairment at 2 years of age after cardiac surgery. It has been hypothesized that altered brain development due to CHD may increase vulnerability to perioperative hemodynamic instability and intraoperative brain injury due to hypoxia and ischemia 34 . Our findings show that low birth weight is at the expense of HC and BPD, with the AC remaining within normal ranges and stable throughout gestation, indicating that placental insufficiency is not the main contributor, but rather a co-existing pathological feature of common angiogenic impairment that may explain abnormal vessel formation as a common pathway in all CHD fetal systems, including the heart, brain and placenta.
Some limitations of this study should be considered. First, owing to the retrospective nature of the study, Doppler parameters were not obtained for all patients. Second, small head size on its own does not necessarily equate to neurodevelopmental delay; thus, as we did not evaluate neurodevelopment in these children, we can only speculate as to a possible relationship between a small head and neurodevelopmental delay. However, it has been demonstrated that fetal brain Doppler and cephalic biometry at the time of CHD diagnosis are independent predictors of abnormal brain development at birth, emphasizing the predictive value of these findings 25 . Third, despite the large number of examinations and cases included in the study, the sample size of each subgroup may still be too limited to draw meaningful conclusions. Also, cases in our study with more severe types of CHD, such as hypoplastic left heart syndrome, were few, which could be considered as a conservative bias; thus, the inclusion of severe cases could have increased the differences observed in CHD cases.
In conclusion, fetuses with CHD had a small head from the second trimester onwards that remained smaller than normal throughout pregnancy, and there was a significant trend towards increased resistance in the UtA and UA. This may indicate a coexistent neurodevelopmental abnormality associated with CHD and a certain degree of placental impairment. Our data confirm the early onset of mechanisms leading to poorer neurodevelopment later in life and suggest a window of opportunity for the prediction and prevention of abnormal neurodevelopment in cases of fetal CHD.
